Tamsulosin and Vardenafil interaction

Tamsulosin and Vardenafil: both prescribing labels describe an interaction that usually calls for monitoring, a dose change, or spacing the doses.

Moderate

Usually manageable with monitoring or a dose change. Tell your pharmacist you take both.

What the FDA labels say

From the Tamsulosin (Tamsulosin Hydrochloride) label · effective 2026-08-12

Moderate

Caution is advised when alpha adrenergic blocking agents including tamsulosin hydrochloride are coadministered with PDE5 inhibitors.

Warnings and precautionsby drug classView label on DailyMed
Moderate

• Concomitant use of PDE5 inhibitors with tamsulosin can potentially cause symptomatic hypotension ( 5.2 , 7.3 , 12.3 )

Drug interactionsby drug classView label on DailyMed
Moderate

PDE5 Inhibitors Caution is advised when alpha adrenergic blocking agents including tamsulosin hydrochloride are coadministered with PDE5 inhibitors.

Drug interactionsby drug classView label on DailyMed
Minor

Alpha-adrenergic blockers and PDE5 inhibitors are both vasodilators that can lower blood pressure.

Warnings and precautionsby drug classView label on DailyMed

From the Vardenafil (Vardenafil Hydrochloride) label · effective 2026-08-27

Moderate

Clinical pharmacology studies have been conducted with co-administration of vardenafil with alfuzosin, terazosin or tamsulosin. [See Dosage and Administration (2.4) , Warnings and Precautions (5.6) , and Clinical Pharmacology (12.2) .] Antihypertensives: Vardenafil hydrochloride tablets may add to the blood pressure lowering effects of antihypertensive agents.

Drug interactionsnames TamsulosinView label on DailyMed
Moderate

Alpha-Blockers : Caution is advised when PDE5 inhibitors are co-administered with alpha-blockers.

Warnings and precautionsby drug classView label on DailyMed
Moderate

Alpha-Blockers Caution is advised when PDE5 inhibitors are co-administered with alpha-blockers.

Warnings and precautionsby drug classView label on DailyMed
Moderate

Consideration should be given to the following: Patients should be stable on alpha-blocker therapy prior to initiating a PDE5 inhibitor.

Warnings and precautionsby drug classView label on DailyMed
Moderate

Patients who demonstrate hemodynamic instability on alpha-blocker therapy alone are at increased risk of symptomatic hypotension with concomitant use of PDE5 inhibitors.

Warnings and precautionsby drug classView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.